Viking Therapeutics has important catalysts on the horizon. Zoetis looks well-positioned to overcome recent challenges.

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, February 12, 2026. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review fourth quarter and full year 2025 financial results and respond to questions from financial analysts. Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-present.

Ethic Inc. decreased its position in Zoetis Inc. (NYSE: ZTS) by 28.9% during the undefined quarter, according to the company in its most recent filing with the SEC. The fund owned 37,851 shares of the company's stock after selling 15,402 shares during the quarter. Ethic Inc.'s holdings in Zoetis were worth $5,538,000 at

Carnegie Investment Counsel lifted its holdings in shares of Zoetis Inc. (NYSE: ZTS) by 6.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 340,532 shares of the company's stock after purchasing an additional 21,563 shares during

Pet spending stayed resilient in 2025 despite inflation. See which pet care stocks Wall Street is watching heading into 2026.

Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to explain why she's buying more Zoetis.

Zoetis (ZTS) closed at $123.78 in the latest trading session, marking a +1.26% move from the prior day.

CHICAGO TRUST Co NA decreased its stake in shares of Zoetis Inc. (NYSE: ZTS) by 43.8% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 6,176 shares of the company's stock after selling 4,818 shares during the quarter. CHICAGO TRUST Co

Figma, Pinterest, and Zoetis are struggling this year due to a combination of high valuations and disappointing earnings. However, they possess some attractive long-term growth opportunities.

Addenda Capital Inc. bought a new position in shares of Zoetis Inc. (NYSE: ZTS) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 29,372 shares of the company's stock, valued at approximately $4,298,000. Several other institutional investors and hedge funds have also